Patients Coming Off Anti-Obesity Medications Regain Pounds Four Times Faster Compared to Those on Conventional Diets

New research indicates that patients who discontinue new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who end traditional lifestyle regimens.

Research printed in a major health publication points out that while overweight individuals can lose substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.

"Individuals purchasing such medications should be aware of the potential of quick rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.

Such speed of recovery means a return to pre-treatment weight in about 18 months.

Weighing Treatments

The analysis, which reviewed 37 of studies involving thousands of participants, compared the effects of GLP-1 agonists with conventional dieting.

Researchers point out that people who lose weight through dieting usually experience a slower creep back—approximately 0.1 kg a month—post-intervention.

Understanding the Quick Regain

Nutrition scientists believe the way of the injections is key to understanding the amplified regain.

The injections mimic a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of GLP-1 concentrations far above than normal might result in the system to produce less of its own natural GLP-1, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Stopping of this medication means appetite is no longer kept in check, making excessive eating much more probable."

A Lifelong Issue?

Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Professionals say that, considering the high risk of relapse, the therapy might need to be ongoing.

This view is supported by pharmaceutical companies, who say that the findings "underscore the persistent nature of excess weight," akin to managing diseases like diabetes.

Patient Testimonies

Individuals who have stopped the jabs explain a powerful return of appetite.

"It felt as if a trigger flipping and you're instantly ravenous," described one woman.

This challenge is exacerbated if users have not developed lasting dietary or behavioural changes during treatment.

Widespread Adoption

Survey data indicate that millions of people in the UK have tried weight-loss jabs in the past year, with desire remaining high.

• Adoption is more common among females than males.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Finally, clinicians stress that while the jabs are effective agents for shedding pounds, they are not a standalone solution and long-term success relies on combined lifestyle changes.